Journal of Psychopharmacology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fedorowicz, V. J.
Right arrow Articles by Fombonne, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fedorowicz, V. J.
Right arrow Articles by Fombonne, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Psychopharmacology, Vol. 19, No. 5, 533-550 (2005)
DOI: 10.1177/0269881105056543
© 2005 British Association for Psychopharmacology

Reviews

Metabolic side effects of atypical antipsychotics in children: a literature review

Valérie J. Fedorowicz, MDCM

McGill University, Montreal Children’s Hospital, Montreal, QC, Canada H32 1P2

Eric Fombonne, MD, FRCPsych (UK)

McGill University, Department of Psychiatry, the Montreal Children’s Hospital, Montreal, QC, Canada H3Z 1P2, eric.fombonne{at}mcgill.ca

The objective of this review is to summarize the data about metabolic side effects of atypical antipsychotics in children.

Original research articles about side effects of atypical antipsychotics used in children were reviewed. The data was obtained mainly through Medline searches, identifying articles focusing on the use of atypical antipsychotics in children. Forty studies that addressed the issue of metabolic side effects were selected.

The use of atypical antipsychotics in children has been consistently associated with weight gain and moderate prolactin elevation, while only a few case reports address the issue of glucose dysregulation and dyslipidaemia. The risk of weight gain and hyperprolactinaemia might be higher in younger children. Other risk factors have also been associated with antipsychotic-induced metabolic disturbances. These changes seem to be reversible, at least in some cases.

Metabolic side effects of atypical antipsychotics could lead to serious complications in children who are prescribed these medications. Serious considerations should be given before initiating treatment and consistent clinical monitoring is essential. More research is needed, especially regarding glucose dysregulation and dyslipidaemia.

Key Words: atypical antipsychotics • weight • glycaemia • diabetes • lipids • prolactin • side effect • metabolic • children • adolescents


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. PsychiatryHome page
K. E. Towbin
Gaining: Pediatric Patients and Use of Atypical Antipsychotics
Am J Psychiatry, December 1, 2006; 163(12): 2034 - 2036.
[Full Text] [PDF]